| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0029 | 1 |